Correlation Between Apellis Pharmaceuticals and Adaptive Biotechnologies

Can any of the company-specific risk be diversified away by investing in both Apellis Pharmaceuticals and Adaptive Biotechnologies at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Apellis Pharmaceuticals and Adaptive Biotechnologies into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Apellis Pharmaceuticals and Adaptive Biotechnologies Corp, you can compare the effects of market volatilities on Apellis Pharmaceuticals and Adaptive Biotechnologies and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Apellis Pharmaceuticals with a short position of Adaptive Biotechnologies. Check out your portfolio center. Please also check ongoing floating volatility patterns of Apellis Pharmaceuticals and Adaptive Biotechnologies.

Diversification Opportunities for Apellis Pharmaceuticals and Adaptive Biotechnologies

0.73

Correlation Coefficient

Apellis Pharmaceuticals  Adaptive Biotechnologies

Poor diversification

The 3 months correlation between Apellis and Adaptive is 0.73. Overlapping area represents the amount of risk that can be diversified away by holding Apellis Pharmaceuticals and Adaptive Biotechnologies Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Adaptive Biotechnologies and Apellis Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Apellis Pharmaceuticals are associated (or correlated) with Adaptive Biotechnologies. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Adaptive Biotechnologies has no effect on the direction of Apellis Pharmaceuticals i.e., Apellis Pharmaceuticals and Adaptive Biotechnologies go up and down completely randomly.

Pair Corralation between Apellis Pharmaceuticals and Adaptive Biotechnologies

Given the investment horizon of 90 days Apellis Pharmaceuticals is expected to generate 3.17 times less return on investment than Adaptive Biotechnologies. But when comparing it to its historical volatility, Apellis Pharmaceuticals is 1.84 times less risky than Adaptive Biotechnologies. It trades about 0.1 of its potential returns per unit of risk. Adaptive Biotechnologies Corp is currently generating about 0.17 of returns per unit of risk over similar time horizon. If you would invest  558.00  in Adaptive Biotechnologies Corp on September 26, 2024 and sell it today you would earn a total of  81.00  from holding Adaptive Biotechnologies Corp or generate 14.52% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Apellis Pharmaceuticals  vs.  Adaptive Biotechnologies Corp

Apellis Pharmaceuticals

Risk-Adjusted Performance

5 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Apellis Pharmaceuticals are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unsteady essential indicators, Apellis Pharmaceuticals unveiled solid returns over the last few months and may actually be approaching a breakup point.

Adaptive Biotechnologies

Risk-Adjusted Performance

8 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Adaptive Biotechnologies Corp are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, Adaptive Biotechnologies unveiled solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Apellis Pharmaceuticals and Adaptive Biotechnologies

The main advantage of trading using opposite Apellis Pharmaceuticals and Adaptive Biotechnologies positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Apellis Pharmaceuticals position performs unexpectedly, Adaptive Biotechnologies can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Adaptive Biotechnologies will offset losses from the drop in Adaptive Biotechnologies' long position.

The idea behind Apellis Pharmaceuticals and Adaptive Biotechnologies Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.